Aveanna Healthcare Holdings Inc. (AVAH)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aveanna Healthcare Holdings Inc. (“Aveanna” or the “Company) (NYSE: AVAH). Investors who purchased Aveanna securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Aveanna and certain of its officers and/or directors have violated federal securities laws.
On or around April 28, 2021, Aveanna conducted its initial public offering, issuing over 38 million shares of its common stock to the public at $12 per share. Then, on March 28, 2022, Aveanna issued its fourth quarter and full year 2021 financial results, reporting fourth quarter GAAP EPS of -$0.68, missing consensus estimates by $0.77; revenue of $414.07 million, representing a 1.9% year-over-year decline, and missing consensus estimates by $3.21 million; and provided full year 2022 revenue guidance of $1.89 - $1.92 billion, missing consensus estimates on projected revenue of $2.02 billion. On this news, Aveanna’s stock price fell $1.44 per share, or 26.72%, to close at $3.95 per share on March 29, 2022.
If you are aware of any facts relating to this investigation or purchased Aveanna shares you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.